Información del artículo
El Texto completo está disponible en PDF
References
[1.]
E. Christophers.
Psoriasis-epidemiology and clinical spectrum.
Clin Exp Dermatol, 26 (2001), pp. 314-320
[2.]
L. Puig, X. Bordas, J.M. Carrascosa, E. Daudén, C. Ferrándiz, J.M. Hernanz, et al.
Documento de consenso sobre la evaluación y el tratamiento de la psoriasis moderada/grave del Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología.
Actas Dermosifiliogr, 100 (2009), pp. 277-286
[3.]
A.B. Gottlieb, U. Chaudhari, D.G. Baker, M. Perate, L.T. Dooley.
The National Psoriasis Foundation Psoriasis Score (NPF-PS) System versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison.
J Drugs Dermatol, 2 (2003), pp. 260-266
[4.]
C. Porto Ferreira, C.J. Martins, P.R. Issa, R. de Vasconcellos Carvalhaes de Oliveira, A.M. Da-Cruz.
Psoriasis affects individuals of African descent and white Brazilians similarly.
Actas Dermosifiliogr, 101 (2010), pp. 230-234
[5.]
L.D. Bogh, T.A. Duling.
Flow cytometry instrumentation in research and clinical laboratories.
Clin Lab Sci, 6 (1993), pp. 167-173
[6.]
A. Koreck, A. Surányi, B.J. Szöny, Á. Farkas, Z. Bata-Csörgö, L. Kemény, et al.
CD3+CD56+NK T cells are significantly decreased in the peripheral blood of patientswith psoriasis.
Clin Exp Immunol, 127 (2002), pp. 176-182
[7.]
H. Sigmundsdottir, J.E. Gudjonsson, I. Jonsdottir, B.R. Ludviksson, H. Valdimarsson.
The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease.
Clin Exp Immunol, 126 (2001), pp. 365-369
[8.]
L.F. Santamaría-Babi.
CLA+ T cells in cutaneous disease.
Eur J Dermatol, 15 (2004), pp. 13-18
[9.]
Y. Teraki, A. Miyake, R. Takebayashi, T. Shiohara.
Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris.
Clin Exp Dermatol, 29 (2004), pp. 658-663
Copyright © 2011. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
